Acute Lymphoblastic Leukaemia Recurrent Recruiting Phase 1 Trials for Sorafenib (DB00398)

Also known as: Acute lymphoblastic leukemia recurrent / Recurrent Acute lymphoblastic leukemia / Acute, recurrent Lymphoblastic Leukaemia / Relapsed ALL / Acute, recurrent Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia / Relapsed Acute Lymphoblastic Leukemia / Acute lymphocytic leukemia recurrent / Acute lymphocytic leukaemia recurrent

IndicationStatusPhase
DBCOND0083559 (Acute Lymphoblastic Leukaemia Recurrent)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03132454Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory LeukemiaTreatment